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INTRODUCTION
Polycystic Ovarian Syndrome (PCOS) was first recognized in
1935 by two Chicago Gynecologists - Dr. Irving Stein and
Michael Leventhal. This syndrome is associated with
amenorrhea, infertility, variable levels of hirsutism and obesity
in the presence of bilaterally enlarged ovaries.1,2 Despite
continuous research in pathophysiology, PCOS remains a
syndrome of heterogeneous disorder. The consensus
conference at Rotterdam in 2003 suggested that diagnosis of
PCOS would be fulfilled if 2 out of the following 3 features are
present: anovulation (usually manifested as oligomenorrhea or
amenorrhea), elevated levels of circulating androgens
(hyperandrogenemia) or clinical manifestation of androgen
excess and presence of polycystic ovaries on
ultrasonographic.3
It is the most common endocrinopathy in women of child
bearing age and has a prevalence of 4-10% in the United
States .4 Estimation of prevalence of PCOS depends on the
nature of population being assessed. There are ethnic and
racial differences in the clinical and biochemical features of
PCOS but the question remains whether the difference in
expression of this syndrome is due to dietary, life style factors
or purely 
genetic familial expression?5 The prevalence in British female
population is 22%.5 The prevalence of this syndrome in
Caribbean-Hispanic women is twice than that in African-
American and Caucasian women.6 There has been no large
scale study to gauge the burden of PCOS in South Asia.
Authors clinical experience and few studies done on South
Asian immigrants settled in England revealed a high frequency
in the South Asian women. A recent epidemio-logical study
was conducted on Austrian infertile Muslim women with
PCOS, which revealed clinically severe symptomatology in
them compared to Jewish and Christian counterparts,7
attributed to inter-marriages. Although the exact role of inter-
family marriages is not yet defined, however, logically, insulin
resistance and polygenic pattern of inheritance of PCOS are
the possible factors for aggravation of clinical and metabolic
features of this syndrome and  metabolic X syndrome.
An obese infertile woman with PCOS is one group who should
be managed with care and caution as they carry morbidity and
metabolic complications, especially during pregnancy.
Studies on demographics and prevalence of this disorder in
South Asian region will be helpful to know the burden of
disease and its associated complications. It is a fact that a
study of these differences would not only contribute a better
understanding of disease mechanism but will aid to formulate
guidelines according to resources and burden of disease.  
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Objective: To evaluate and compare the clinical, biochemical and ultrasonic features of infertile women with PCOS from the two
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The objective of this study was to evaluate and compare the
clinical, biochemical and ultrasonic features of infertile women
with PCOS from the two infertility centers of Karachi, The Aga
Khan University Hospital, and Concept Fertility Centre. 
PATIENTS AND METHODS
This study was carried out on infertile women, attending the
two infertility centers of Karachi, from January 2003 to
December 2004. A total of 2,884 infertile couples were seen
and treated at these centers. A total of 1,476 couples were
treated at Aga Khan University Hospital while 1,408 were
managed at Concept Fertility Center.  The diagnostic criterias
adopted for PCOS were according to Rotterdam 2003
consensus workshop, its menstrual irregularity i.e. long cycle
of >35 days, hirsutism (facial and truncal) acne, tonic LH levels
i.e.> 10 U/L and ultrasonographic morphology of ovaries i.e.
presence of more than 8 small follicles measuring less than 10
mm in subcortical region and total ovarian volume of more
than 10 ml.
The clinical, biochemical and ultrasonographic features of
women with PCOS were recorded on a data collection form
with respect to age, type and duration of infertility, history of
menstrual cycle, hair growth, weight gain, and family history of
diabetes mellitus. The biochemical hormonal evaluation was
performed by Day 2 FSH, LH, prolactin levels. Fasting insulin
and fasting blood glucose were also checked. Reports of
transvaginal ultrasound to check ovarian morphology were
recorded. 
The normal cutoff for FSH, LH and fasting insulin was taken
less than 10 iu/l. Prolactin was taken as normal if less than
25ng/dl. BMI was calculated by dividing the weight in
kilograms from height in meter square. For BMI, reference
standards were taken as defined by WHO for South Asian
women i.e. BMI > 25 is taken as type I obesity. In order to have
more clear demarcation of lean and obese patients with
PCOS, BMI was categorized from 18 or less to 35 or more. 
Women who had other causes of infertility like tubal factor,
uterine and male factor were excluded from the study. Data
analysis was performed by SPSS version 13. Five hundred
and eight women met the criteria of PCOS, making a
frequency of 17.6% in those infertility clinics. Out of 508
patients, 476 women, who had a BMI of > 25, were included
for univariate and multivariate analysis.
Correlations were done by Pearson test. Categorical variables
were compared by using Chi-square test and for continuous
variables, t-test was used for comparing women with PCOS in
different group of BMI. Two tailed significance was calculated
and p–value of < 0.05 was taken as significant. The
association of different clinical, biochemical and ultrasonic
features with BMI was analyzed at univariate and multivariate
levels and adjusted R-value and p-value were calculated to
show statistical significance.
RESULTS
Study population consisted of women of reproductive age
group. The mean age of women was 27.1 + 4.5. Table I
describes the percentage distribution of normal and  abnormal
clinical, biochemical and ultrasonographic features from these
two centers.  Out of 508 studied women, the rate of obesity
was 68.5% while 58.9% of them had varying degree of
hirsutism and 59% had hyperinsulinemia. Menstrual
irregularity was found in 74.2% of studied infertile women with
PCOS. Almost half of them i.e. 48% had first degree inter-
family marriages. Out of 508 infertile couples, 63.7% of them
had primary infertility while 37.7% had a presentation with
secondary infertility. Majority of studied women were from
infertility clinics of Aga Khan University Hospital i.e. 80.3%
compared to 17.7% from Concept Fertility Centre, Karachi.
Hormonal essay revealed that 94.5% had normal FSH while
66.6% had normal LH levels. Family history of diabetes was
strongly positive in 54% of infertile women, with PCOS. Out of
508 studied women, 33.5 % had impaired GTT while 10.1%
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Table I: Percentage distribution of different characteristics.
Characteristics AKU Concept Mean %age
Age
22.5 36.2% 23.6% 29.4%
25-29 42.7% 43.8% 43.1%
30-34 19.6% 23.7% 21.6%
35 and above 5.2% 7.1% 6.1%
Mean age (SD) 27.1+4.5
BMI
<18.5 (underweight) 1.5 2.6 1.9%
18.5-22.9 (n) 16.2 12.3 14.1%
23-24.9 (even) 14.9 16.2 15.5%
25-29.9 41.2 37.3 39.7%
30 above 30.1 27.3 28.8%
Mean BMI (SD) 27.7+5.07
FSH level
Normal 95.6 93.2 94.5%
Abnormal 4.6% 6.3% 5.5%
LH level
Normal 61.6% 71.4% 46.6%
Abnormal 38.4% 28.6% 33.3%
Prolactin level
Normal 70.4 820 76.1%
Abnormal 29.6 18 23.9%
Insulin level
Normal 46.3% 37.2% 41%
Abnormal 53.7% 62.8% 59%
PCOS detection
through ultrasound
Yes 65.2% 73.1% 69.7%
No 34.8% 26.9% 30.3%
Hirsutism
Yes 60.1% 28.2 58.9%
No 39.9 41.8 41.1%
Family history of 
diabetes
Yes 56.3 52% 54%
No 43.7 48% 46%
Inter-family marriages
Yes 56.3 40.2% 48%
No 43.7 59.8 52%
GTT
Normal 52.3 50.9 56.3%
Impaired 36.1 31.2 33.7%
Abnormal 11.6 8.9% 10.1%
Total sampled 408 100 508
had abnormal GTT showing diabetes mellitus. Only 14% of
women had normal BMI while 29.7% had BMI of 30 and 28.8%
had a BMI above 30-35.
Table II and III shows analysis and association of abnormal,
clinical, and biochemical features with BMI at univariate and
multivariate levels. Out of 508 women,  476 were included for
variate analysis having a BMI > 25 . By using appropriate
co-efficient (R2 and F-Change), statistical significance was
declared significant if p-value was < 0.05. Menstrual cycle
irregularity, serum LH levels, hyperinsulinemia and family
history of diabetes had a strong association  with high BMI i.e.
> 25 ( p-value 0.01-0.001).
DISCUSSION
In this study, the clinical symptomatology, biochemical and
ultrasonographic features of infertile patient with PCOS were
evaluated. An effort was made to compare the severity of
clinical, biochemical features with other investigating
counterparts from the west.10-12 One of the major difficulties in
the analysis of PCOS is the great variability in clinical and
biological manifestations of this condition. The spectrum of this
syndrome ranges from infertility as a result of chronic
anovulation and menstrual irregularities such as amenorrhea
or oligomenorrhea, apple type obesity and certain
dermatological manifestations such as alopecia, acne or
hirsutism as a result of hyperandrogenism.9
Most of the research to determine the ethnic, demographic,
epidemiologic, and metabolic derangements of PCOS has
been performed in the women of western region. The
frequency of PCOS in infertile patients, visiting the study
centres was comparable to the rates mentioned from infertility
centers in Britain and United States i.e. 20-25%.8,9 The
diagnostic criterias used to identify the PCOS were according
to Consensus Opinion of Rotterdam 2003. Study results
revealed a high frequency of obesity, hyperinsulinemia, and
tonic LH levels in this group of patients compared to the rest of
studies.10-12 The WHO global data based on obesity and BMI
in adults from different ethnic groups has recently redefined
obesity in South Asian women: a BMI > 25 is regarded as
class I obesity which is considered equivalent to BMI > 30 for
Caucasian women.5
PCOS is a disorder in which an association exists between
insulin resistance and altered ovarian function. The
pathophysiology of PCOS has been explained by an insulin
receptor-mediated stimulation of steroidogenesis in the
ovary. 13 PCOS is most of the time co-existent with
hyperinsulinemia or insulin resistance, which is the key factor
for aggravation of ovulation dysfunction and metabolic
derangements.8,9 Insulin-resistant states are helpful to explain
the ovarian dysfunction observed in women with type II
diabetes mellitus, obesity, insulin resistance syndrome and
PCOS. In this study, the infertile women with PCOS who were
diabetic and had impaired glucose tolerance had more severe
symptomatology of oligomenorrhea, hirsutism, tonic LH and
hyperinsulinemia.13 When women with type II diabetes and
impaired glucose tolerance were evaluated for the presence of
PCOS, 45-50% of them were found to have PCOS compared
to the controls of non-diabetic women.13-15
It has been demonstrated in various studies that
hyperinsulinemia and insulin resistance are independent of
body weight but worsened by obesity. 6,15 Thus, a pregnancy in
these PCOS patients is an additional provocating risk factor for
impaired carbohydrate metabolism and placental vascular
insufficiency.15 In this study, the subjects were infertile women
with PCOS, identifying their extent of metabolic problems
would aid in counseling, further evaluation and management.
The significant differences in insulin concentration and insulin
sensitivity in South Asian women with PCOS when compared
to their Caucasian and European counterparts, suggest a
definite ethnic role.5
Although the role of hyperinsulinemia in hyperandrogenism
and ovulatory dysfunction of PCOS appears most prominent in
obese women, the response to insulin sensitizing agents in
lean women suggest that this mechanism may be operative
across a broad spectrum of patients with PCOS.17 Studies
have shown that 40% of women with PCOS have higher
fasting insulin levels15,16 but results of 508 patients of this
study reveals much high rates of hyperinsulinemia i.e. 59%. It
has been shown that there is an association of different groups
of BMI ranging from 18-40 with the rate of cycle abnormalities,
hirsutism, family history of diabetes mellitus, tonic LH levels,
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Table II: The association of different factors with BMI at univariate level.
Characteristic Estimated Coefficient of  p-value
Slope (SE) determination (r2)
Centre
AKU (Ref.) concept 0.04 (0.585) 9.8x10-6 0.946
Menstrual cycle
Normal (Ref.) abnormal 1.90 (0.524) 0.027 <0.001*
FSH level in the body
Normal (Ref.) abnormal 0.57 (1.024) 0.001 0.578
LH level in the body
Normal (Ref.) abnormal 1.56 (0.488) 0.021 0.002*
Prolactin level in the body
Normal (Ref.) abnormal 0.29 (0.545) 0.001 0.600
Hirsutism
Normal (Ref.) abnormal 2.284(0.674) 0.002 0.036*
Family history of diabetes
Normal (Ref.) abnormal 2.362(0.676) 0.001 0.021*
Total sampled (n) 476
*Women with BMI of more than 25, i.e. 476, are included for variate analysis.
Table III: The association of different factors with BMI at multivariable 
level.
Characteristic Estimated adjusted slope (SE) p-value
Constant (intercept) 24.38 (0.509) -
Centre
AKU (Ref.) concept -0.38 (0.550) 0.485
Menstrual cycle
Normal (Ref.) abnormal 1.68 (0.499) 0.001*
LH level in the body
Normal (Ref.) abnormal 1.16 (0.464) 0.013*
Hirsutism
Normal (Ref.) abnormal 2.484(0.774) 0.002*
Family history of diabetes
Normal (Ref.) abnormal 2.962(0.776) <0.001*
F-Statistic 17.863 (p-value<0.001)*
Total sampled (n) 476
*Women with BMI of more than 25, i.e. 476, are included for variate analysis. 
extent of abnormal insulin levels and impaired glycemic
controls. At univariate and multivariate analysis, a statistically
significant difference of above mentioned changes was found
in a group of women with BMI of over 30. 
In this study, results of hypeinsulinemia were comparable with
the results of Indian, Sri Lankan and a study done on South
Asian immigrants in UK, which have shown the incidence of
55-60% in their respective studies.5 The reasons could be
genetic, ethnic and racial pre-disposition of insulin resistance
in this population and also due to high rates of first degree
marriages among families of Muslim population. These
factors, most probably, have magnified the abnormal
metabolic and clinical parameters of PCOS. In the Rotterdam’s
2003 consensus, clinical hirsutism is one of the features of
PCOS. In this study 52% of women with PCOS and infertility
had varying degree of hirsutism but when a comparison was
made with their LH and testosterone levels, it was not a
statistically strong association. This suggests a high frequency
of constitutional hirsutism in female population of this region. 
Pregnancy carries considerable risk for women who are
obese, and have hyperinsulinemia. This is due to increased
chances of congenital anomalies (neural tube and cardiac
defects), miscarriages, gestational diabetes, preeclampsia,
pregnancy induced hypertension and problems during
delivery.18-20
Pregnancy exacerbates any underlying insulin resistance and,
as a result, women with PCOS having obesity and pre-existing
hypeinsulinemia are at risk of carrying all the above mentioned
complications.21,22 Confidential enquiry of maternal deaths in
England and Wales revealed that out of 261 maternal
mortalities, 35% were morbidly obese having a BMI of > 35.20
Infact studies of this nature will be helpful to know the burden
of disease and its associated complications. Moreover, it will
aid to counsel these women and establish guidelines
according to the regional burden of disease and the resources
available. Counseling should be directed to reduce a weight,
as studies have shown an improved endocrine profile,
menstrual cycle, the rate of ovulation and the likelihood of
successful pregnancy in women with enthusiastic reduction of
at least 10% of body weight.16 National guidelines in the
United Kingdom for managing overweight women with PCOS,
advise weight loss, preferably to BMI of less than 30 before
starting drugs for ovarian stimulation.21 The obvious question
is should this rule to be applied on women with BMI of >25
from South Asian region? (WHO defines obesity as BMI > 25
in Asian population?)
CONCLUSION
A significant high rate of obesity and hyperinsulinemia has
been observed in a studied group of infertile women with
PCOS from these centers. It enables the treating clinician to
anticipate the burden of metabolic complications of this
syndrome while treating infertility and thereafter in pregnancy.  
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